Notal Vision

Notal Vision is a digital healthcare provider that offers remote monitoring services to support physicians' AMD patient care. Founded in 2000 and headquartered in the United States, Notal Vision is a patient-centric ophthalmic remote monitoring services provider extending retinal disease monitoring from the clinic to the home. The company's Monitoring Center, supported by certified ophthalmic professionals, offers a comprehensive nationwide age-related macular degeneration (AMD) home monitoring service for referred patients. The latest investment for Notal Vision was a $60.00M Series D investment on 01 June 2021, with participation from Elron Ventures, Ganot Capital, Soleus Capital, and Evergreen Venture Partners. Notal Vision's ForeseeHome® AMD Monitoring Program helps physicians detect the conversion to wet AMD early, leading to earlier treatment intervention and better visual outcomes. The company's Home OCT pipeline technology aims to provide patient-initiated retinal OCT scans to support the management of patients with neovascular retinal diseases, complementing existing in-office imaging and standard of care treatments as well as emerging longer acting drugs and drug delivery systems. With a proven approach to home-based, self-operated diagnostics, AI-enabled data analysis, and patient engagement, Notal Vision aims to preserve patients’ vision by providing physicians with remote monitoring services to support their patient care between office visits.